Credit Suisse’s Kura Oncology KURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
$1.55M Buy
72,494
+3,292
+5% +$70.2K ﹤0.01% 2014
2023
Q4
$995K Sell
69,202
-2,690
-4% -$38.7K ﹤0.01% 2331
2023
Q3
$656K Sell
71,892
-7,718
-10% -$70.4K ﹤0.01% 2528
2023
Q2
$842K Buy
79,610
+7,706
+11% +$81.5K ﹤0.01% 2493
2023
Q1
$879K Buy
71,904
+6,856
+11% +$83.8K ﹤0.01% 2393
2022
Q4
$807K Buy
65,048
+12,289
+23% +$153K ﹤0.01% 2468
2022
Q3
$721K Buy
52,759
+5,661
+12% +$77.4K ﹤0.01% 2549
2022
Q2
$863K Sell
47,098
-3,552
-7% -$65.1K ﹤0.01% 2477
2022
Q1
$815K Buy
50,650
+1,267
+3% +$20.4K ﹤0.01% 2649
2021
Q4
$692K Buy
49,383
+5,938
+14% +$83.2K ﹤0.01% 2825
2021
Q3
$814K Sell
43,445
-14,282
-25% -$268K ﹤0.01% 2708
2021
Q2
$1.2M Buy
57,727
+15,625
+37% +$326K ﹤0.01% 2512
2021
Q1
$1.19M Sell
42,102
-601,022
-93% -$17M ﹤0.01% 2482
2020
Q4
$21M Buy
643,124
+32,574
+5% +$1.06M 0.01% 816
2020
Q3
$18.7M Buy
610,550
+547,762
+872% +$16.8M 0.01% 769
2020
Q2
$1.02M Buy
62,788
+47,059
+299% +$767K ﹤0.01% 2311
2020
Q1
$157K Sell
15,729
-27,283
-63% -$272K ﹤0.01% 3115
2019
Q4
$591K Buy
43,012
+20,559
+92% +$282K ﹤0.01% 2820
2019
Q3
$341K Buy
22,453
+3,371
+18% +$51.2K ﹤0.01% 2985
2019
Q2
$375K Buy
19,082
+4,731
+33% +$93K ﹤0.01% 2936
2019
Q1
$238K Buy
14,351
+1,518
+12% +$25.2K ﹤0.01% 3118
2018
Q4
$180K Sell
12,833
-5,309
-29% -$74.5K ﹤0.01% 3156
2018
Q3
$318K Buy
18,142
+4,869
+37% +$85.3K ﹤0.01% 3023
2018
Q2
$241K Buy
+13,273
New +$241K ﹤0.01% 3242
2017
Q4
Sell
-12,761
Closed -$190K 3566
2017
Q3
$190K Buy
+12,761
New +$190K ﹤0.01% 3457